This latest move is set to improve access to the first Food and Drug Administration (FDA)-cleared wearable medical device for RLS symptoms, potentially benefiting millions of patients. The Nidra TOMAC therapy, which received FDA marketing authorisation as a breakthrough device in the US last year...